Awardee OrganizationUNIVERSITY OF CONNECTICUT SCH OF MED/DNT
Description
Abstract Text
The formation of myelin sheath in the CNS by oligodendrocytes (OL) is a
complex developmental process with numerous intermediate steps.
Programmed myelin gene expression is regulated by both genetic factors
intrinsic to these cells,and by environmental influences encountered as
the cells proliferate and migrate from their sites of embryological origin
to their neurons. During this period OL progenitor differentiation
proceeds along a specific lineage pathway in a highly regulated sequence
of events, resulting in the formation of myelinated neuronal axons. This
project aims to increase our understanding of how extrinsic factors
regulate OL differentiation and myelin formation by identifying and
characterizing environmental factors that regulate myelinogenesis,and by
analyzing the cellular and molecular mechanisms by which they operate.
The project focuses on events occuring during the early stages of
myelinogenesis,during which progenitor cells become committed specifically
to the lineage,and differentiate into identifiable OL. A critical step in
this developmental lineage,characterized experimentally by the expression
of the O4 antigen but the absence of galactocerebroside (i.e., O4+GalC-
),will be examined. During this stage the progenitor cells are triggered
to initiate the cascade of terminal differentiation,heralded by the
expression of galactocerebroside,and followed sequentially by a complement
of myelin-specific structural components. We have recently developed a
procedure for the immuno-isolation of O4+GalC- cells. Two subpopulations
exist within the isolated O4+GalC- progenitor population, a major (80%)
subpopulation of "proligodendrocytes" that rapidly and synchronously
differentiate into authentic OL in culture,and a minor (20%) subpopulation
of "procrastocytes" that remain GalC-. These two coexisting populations
will be further characterized with the regard to the environmental
regulation of their survival,proliferation,migration,and
differentiation,by both previously identified "broad spectrum" growth
factors and by novel activities that we have demonstrated in cell-
conditioned media. These studies will emphasize the analysis of the
cellular mechanisms involved,and the purification and characterization of
previously unidentified factors.
We have shown that the differentiation of OL progenitors in dissoclated
cultures of rat brain can be either stimulated or reversibly inhibited
during this critical developmental stage by OL-specific monoclonal
antibodies,in particular anti-galactolipids. We have hypothesized that
the target antigens act as receptors and ligands in the response of OL to
their environment. An analysis will be carried out to determined (a) the
cellular and biochemical mechanisms by which these antibody pertubations
proceed,(b) the identification of the molecular identities of the cell
surface complexes of which these antigens are a part,and (c) the target
binding sites on OL themselves and on other cells with which these
oligodendrocyte surface antigens interact.
These data will contribute to our understanding of a critical step of OL
differentiation,thereby providing useful clues to processes critical to
myelin formation,maintenance,and remyelination in both the normal and
pathological state. In particular,these data are expected to bear on the
stimulation of remyelination in disease states such as Multiple Sclerosis
by providing information of the information of the environmental
requirements for the successful transplantation of OL progenitors and the
activation of dormant progenitors that appear to exist in the adult CNS.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
022254226
UEI
H6D6JMXJXDE6
Project Start Date
01-January-1977
Project End Date
31-December-1994
Budget Start Date
01-January-1993
Budget End Date
31-December-1993
Project Funding Information for 1993
Total Funding
$217,192
Direct Costs
$139,930
Indirect Costs
$77,262
Year
Funding IC
FY Total Cost by IC
1993
National Institute of Neurological Disorders and Stroke
$217,192
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS010861-19
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS010861-19
Patents
No Patents information available for 5R01NS010861-19
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS010861-19
Clinical Studies
No Clinical Studies information available for 5R01NS010861-19
News and More
Related News Releases
No news release information available for 5R01NS010861-19
History
No Historical information available for 5R01NS010861-19
Similar Projects
No Similar Projects information available for 5R01NS010861-19